Growth Metrics

Veracyte (VCYT) Gains from Investment Securities (2016 - 2025)

Veracyte's Gains from Investment Securities history spans 14 years, with the latest figure at -$12.6 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 217.37% year-over-year to -$12.6 million; the TTM value through Dec 2025 reached -$15.3 million, down 244.44%, while the annual FY2025 figure was -$15.3 million, 244.44% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was -$12.6 million at Veracyte, up from -$14.5 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $10.7 million in Q4 2024 and bottomed at -$14.5 million in Q3 2025.
  • The 5-year median for Gains from Investment Securities is $710000.0 (2021), against an average of $107631.6.
  • The largest annual shift saw Gains from Investment Securities soared 14300.0% in 2021 before it crashed 2954.43% in 2023.
  • A 5-year view of Gains from Investment Securities shows it stood at -$8.1 million in 2021, then soared by 64.84% to -$2.8 million in 2022, then soared by 341.72% to $6.9 million in 2023, then skyrocketed by 55.88% to $10.7 million in 2024, then crashed by 217.37% to -$12.6 million in 2025.
  • Per Business Quant, the three most recent readings for VCYT's Gains from Investment Securities are -$12.6 million (Q4 2025), -$14.5 million (Q3 2025), and $2.4 million (Q2 2025).